The 5th annual symposium of UPMC, entitled “STEREOTACTIC RADIOTHERAPY” took place on October 12-13, 2017 in the premises of the Chamber of Commerce in Rome (Sala del Tempio di Adriano). The event was free and accredited on Agenas for the provision of 14,3 CME credits.
The UPMC Symposium aimed to foster a debate among stakeholders on the application and the results of stereotactic treatments for neoplastic diseases in different body districts, and for palliative therapies.
The two-day program focused, the first day, on intracranial radiosurgery and stereotactic radiotherapy techniques for the treatment of five different diseases (meningioma, head and neck cancer recurrence, post-surgical macroscopic prostate recurrence, low/intermediate risk prostate tumor, locally advanced pancreatic cancer), and for palliations of metastatic cancer diseases, the second day. A multidisciplinary team of radiotherapists, interventional radiologists and surgeons (45 between speakers and moderators from all over Italy, US and Germany) participated in each session and discussed the different approaches applied to real clinical cases. The discussion focused on whether radiosurgery should be used, and on the possible dose and fraction convergence used. The event, endorsed by ESTRO (European Society for Radiology and Oncology) and AIRO (Italian Association for Oncology Radiotherapy) and supported by Brainlab, EL.SE, Ferring Farmaceutici, GE Healthcare, Ipsen, Janssen Oncology and Varian, was streamed on Youtube.
The event welcomed a total of 110 participants coming from all over Italy, Morocco, Germany, and Netherlands, including physicians, physicists, radiotherapy technicians, nurses and other health professionals).
Download the symposium program.